H2-Receptor Antagonists and Gastric Cancer-Reference-Cited by-同舟云学术

H2-Receptor Antagonists and Gastric Cancer

Published:1986-06 Issue:3 Volume:1 Page:163-168
ISSN:0112-5966
Container-title:Medical Toxicology
language:en
Short-container-title:Medical Toxicology

Author:

Pension J.,Wormsley K. G.

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF03259835.pdf

Reference49 articles.

1. Barnard J, Darkin DW, Howard OM, Lightfoot NF, Milton-Thompson GJ, et al. N-nitrosocompounds in cimetidine-treated duodenal ulcer patients. Gut 24: A974, 1983

2. Bavin PMG, Durant GJ, Miles PD, Mitchell RC, Pepper ES. Ni-trosation of cimetidine (N’’-cyano-N-methyl-N’-(2-((5-methyl-imidazol-4-yl) methyl-thio) ethyl) guanidine). Journal of Chemical Research (5): 212–213, 1980

3. Betton GR, Salmon GK. Pathology of the forestomach in rats treated for 1 year with a new histamine H2-receptor antagonist, SKF93479 trihydrochloride. Scandinavian Journal of Gastroenterology 19 (Suppl. 101): 103–108, 1984

4. Bokelman DL. Famotidine: a potent histamine H2-receptor antagonist. Summary of preclinical safety assessment. Italian Journal of Gastroenterology 16: 176–177, 1984

5. Brambilla G, Cavanna M, Faggin P, Maura A, Pino A, et al. Genotoxic effects in rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis 4: 1281–1285, 1983

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-Related Increases and Decreases in Calcium Signaling at the Endoplasmic Reticulum-Mitochondria Interface (MAMs);Reviews of Physiology, Biochemistry and Pharmacology;2020

2. Digestive System;Histopathology of Preclinical Toxicity Studies;2012

3. Digestive System;Histopathology of Preclinical Toxicity Studies;2007

4. Digestive System 1;Histopathology of Preclinical Toxicity Studies;2000

5. Safety Profile of Ranitidine;Drugs;1993-12